Codi QR

Role of corticosteroid therapy in IgA nephropathy; where do we stand?

Background: Current KDIGO guidelines suggest corticosteroids (CS) administration in IgA nephropathy (IgAN) with persistent proteinuria >1 g/d despite 3-6 months of supportive care and estimated glomerular filtration rate (eGFR) >50 mL/min/1.73 m2 . The benefits of CS in patients with eGFR <50 mL/min...

Descripció completa

Guardat en:
Autors principals: Shankar Prasad Nagaraju, Sindhura Lakshmi Koulmane Laxminarayana, Aswani Srinivas Mareddy, Srikanth Prasad, Sindhu Kaza, Srinivas Shenoy, Karan Saraf, Dharshan Rangaswamy, Ravindra Prabhu Attur, Rajeevalochana Parthasarathy, Uday Venkat Mateti, Vasudeva Guddattu, Mahesha Vankalakunti
Format: Artigo
Idioma:Inglês
Publicat: Society of Diabetic Nephropathy Prevention 2017-10-01
Col·lecció:Journal of Nephropathology
Matèries:
iga nephropathy
egfr
corticosteroids
immunosuppression
proteinuria
Accés en línia:https://nephropathol.com/PDF/jnp-6-368.pdf
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars